7.6
CVE-2025-52653
- EPSS 0.05%
- Published 03.10.2025 17:59:44
- Last modified 08.10.2025 16:50:59
- Source psirt@hcl.com
- Teams watchlist Login
- Open Login
HCL MyXalytics product is affected by Cross Site Scripting vulnerability in the web application. This can allow the execution of unauthorized scripts, potentially resulting in unauthorized actions or access.
Data is provided by the National Vulnerability Database (NVD)
Hcltech ≫ Dryice Myxalytics Version6.6
Zu dieser CVE wurde keine CISA KEV oder CERT.AT-Warnung gefunden.
| Type | Source | Score | Percentile |
|---|---|---|---|
| EPSS | FIRST.org | 0.05% | 0.142 |
| Source | Base Score | Exploit Score | Impact Score | Vector string |
|---|---|---|---|---|
| nvd@nist.gov | 5.4 | 2.3 | 2.7 |
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N
|
| psirt@hcl.com | 7.6 | 2.1 | 5.5 |
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:H/I:L/A:H
|
CWE-79 Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting')
The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users.